Early PCSK9 Inhibition in AMI Yields Plaque Regression
"Go early and go low" is an expert's response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received alirobumab.
Medscape Medical News
source https://www.medscape.com/viewarticle/971582?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/971582?src=rss
Comments
Post a Comment